FARALLON CAPITAL MANAGEMENT LLC Q2 2020 Filing
Filed August 14, 2020
Portfolio Value
$12.2B
Holdings
116
Report Date
Q2 2020
Filing Type
13F-HR
All Holdings (116 positions)
| Stock | Value |
|---|---|
IQVIQVIA HLDGS INC | $538.6M |
FISFIDELITY NATL INFORMATION SV | $481.4M |
IACIEURIAC INTERACTIVECORP | $456.0M |
CNCCENTENE CORP DEL | $444.9M |
ABBVABBVIE INC | $407.4M |
TMOTHERMO FISHER SCIENTIFIC INC | $387.5M |
CHTRCHARTER COMMUNICATIONS INC N | $385.1M |
TMUST-MOBILE US INC | $360.1M |
VVISA INC | $347.6M |
AONAON PLC | $331.4M |
ELVANTHEM INC | $328.7M |
GOOGALPHABET INC | $312.5M |
MSFTMICROSOFT CORP | $311.0M |
METAFACEBOOK INC | $308.5M |
—IHS MARKIT LTD | $295.2M |
CRMSALESFORCE COM INC | $285.8M |
WUBAUSD58 COM INC | $267.8M |
SHWSHERWIN WILLIAMS CO | $258.9M |
WABWABTEC | $249.0M |
EX9EXELIXIS INC | $243.3M |
BMYBRISTOL-MYERS SQUIBB CO | $213.2M |
XLRNACCELERON PHARMA INC | $200.1M |
BABAALIBABA GROUP HLDG LTD | $199.9M |
PANWPALO ALTO NETWORKS INC | $195.7M |
EQIXEQUINIX INC | $187.9M |
IOVAIOVANCE BIOTHERAPEUTICS INC | $179.5M |
NYTNEW YORK TIMES CO | $173.9M |
GDGENERAL DYNAMICS CORP | $172.1M |
ASNDASCENDIS PHARMA A S | $168.6M |
BMY-RBRISTOL-MYERS SQUIBB CO | $158.2M |
BXBLACKSTONE GROUP INC | $156.9M |
ALNYALNYLAM PHARMACEUTICALS INC | $155.5M |
—QIAGEN NV | $123.3M |
FATEFATE THERAPEUTICS INC | $120.1M |
PLYAPLAYA HOTELS & RESORTS NV | $110.8M |
TRUTRANSUNION | $103.8M |
CZREURCAESARS ENTMT CORP | $97.2M |
CICIGNA CORP NEW | $93.8M |
—BROADMARK RLTY CAP INC | $90.5M |
ENTAENANTA PHARMACEUTICALS INC | $87.9M |
—MYOKARDIA INC | $84.5M |
SRPTSAREPTA THERAPEUTICS INC | $84.2M |
EDUNEW ORIENTAL ED & TECHNOLOGY | $82.2M |
MRTXEURMIRATI THERAPEUTICS INC | $74.2M |
APLSAPELLIS PHARMACEUTICALS INC | $73.5M |
AGIOAGIOS PHARMACEUTICALS INC | $66.8M |
FGENEURFIBROGEN INC | $65.9M |
MOMO 1.25 07/01/25MOMO INC | $64.2M |
KRTXKARUNA THERAPEUTICS INC | $64.1M |
IQ 2 04/01/25IQIYI INC | $61.4M |
GRFSGRIFOLS S A | $56.8M |
ARNAEURARENA PHARMACEUTICALS INC | $56.7M |
—ZOGENIX INC | $54.0M |
KPTI 3 10/15/25KARYOPHARM THERAPEUTICS INC | $50.3M |
ZNTLZENTALIS PHARMACEUTICALS INC | $47.6M |
GBIOGBXGENERATION BIO CO | $44.5M |
PTGXPROTAGONIST THERAPEUTICS INC | $44.1M |
EFXEQUIFAX INC | $43.9M |
DCPHEURDECIPHERA PHARMACEUTICALS IN | $42.7M |
UTHUNITED THERAPEUTICS CORP DEL | $42.4M |
—THERAVANCE BIOPHARMA INC | $40.9M |
CARAEURCARA THERAPEUTICS INC | $39.3M |
LNTHLANTHEUS HLDGS INC | $37.7M |
CYTKCYTOKINETICS INC | $35.4M |
SG7SAGE THERAPEUTICS INC | $35.3M |
ARWRARROWHEAD PHARMACEUTICALS IN | $34.6M |
—PORTOLA PHARMACEUTICALS INC | $33.2M |
—IQIYI INC | $33.1M |
CLVS 1.25 05/01/25CLOVIS ONCOLOGY INC | $31.2M |
AMRSEURAMYRIS INC | $29.9M |
—HORIZON PHARMA INVT LTD | $29.4M |
TGTXTG THERAPEUTICS INC | $29.2M |
—RADIUS HEALTH INC | $28.6M |
—FORESCOUT TECHNOLOGIES INC | $27.7M |
PLRXPLIANT THERAPEUTICS INC | $27.6M |
—AVROBIO INC | $27.5M |
KPTIEURKARYOPHARM THERAPEUTICS INC | $25.3M |
ADAPYADAPTIMMUNE THERAPEUTICS PLC | $25.0M |
RCUSARCUS BIOSCIENCES INC | $24.7M |
FXIISHARES TR | $22.3M |
VCYTVERACYTE INC | $22.0M |
AMRNAMARIN CORP PLC | $21.6M |
GOSS 5 06/01/27GOSSAMER BIO INC | $20.0M |
NVTA1EURINVITAE CORP | $19.9M |
—ZYMEWORKS INC | $19.8M |
HWMHOWMET AEROSPACE INC | $19.0M |
—INTERCEPT PHARMACEUTICALS IN | $19.0M |
KRYSKRYSTAL BIOTECH INC | $18.6M |
—PRINCIPIA BIOPHARMA INC | $17.9M |
—ZEALAND PHARMA A S | $17.5M |
LQDALIQUIDIA TECHNOLOGIES INC | $15.6M |
1T7TRICIDA INC | $13.7M |
QUREUNIQURE NV | $13.5M |
RPRXROYALTY PHARMA PLC | $13.4M |
RCREADY CAPITAL CORP | $11.7M |
YB4PSAVARA INC | $11.1M |
CRSPCRISPR THERAPEUTICS AG | $11.0M |
—CONSTELLATION PHARMCETICLS I | $10.5M |
PACBPACIFIC BIOSCIENCES CALIF IN | $10.3M |
AKBAAKEBIA THERAPEUTICS INC | $10.2M |
Page 1 of 2Next